Free Trial

Barclays PLC Has $48.86 Million Position in The Clorox Company (NYSE:CLX)

Clorox logo with Consumer Staples background

Barclays PLC cut its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 53.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 300,843 shares of the company's stock after selling 350,454 shares during the quarter. Barclays PLC owned 0.24% of Clorox worth $48,859,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in CLX. Trustmark National Bank Trust Department acquired a new stake in Clorox during the fourth quarter worth about $215,000. Savvy Advisors Inc. bought a new stake in shares of Clorox during the 4th quarter worth approximately $946,000. Rockefeller Capital Management L.P. boosted its position in shares of Clorox by 5.6% during the 4th quarter. Rockefeller Capital Management L.P. now owns 16,003 shares of the company's stock worth $2,599,000 after acquiring an additional 847 shares in the last quarter. Heritage Trust Co bought a new position in Clorox in the fourth quarter valued at approximately $466,000. Finally, Redwood Park Advisors LLC acquired a new position in Clorox during the fourth quarter valued at approximately $26,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. JPMorgan Chase & Co. decreased their price target on Clorox from $173.00 to $151.00 and set a "neutral" rating on the stock in a research note on Friday, April 11th. Royal Bank of Canada reiterated a "sector perform" rating and set a $150.00 price target on shares of Clorox in a report on Thursday, January 30th. Citigroup decreased their price objective on Clorox from $165.00 to $150.00 and set a "neutral" rating for the company in a report on Monday, April 14th. DA Davidson lowered their target price on Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research report on Wednesday, February 5th. Finally, Evercore ISI upped their price target on Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $153.83.

Check Out Our Latest Stock Report on Clorox

Clorox Trading Down 0.6 %

CLX traded down $0.81 during trading on Wednesday, hitting $140.00. The company's stock had a trading volume of 220,626 shares, compared to its average volume of 1,299,308. The firm has a market capitalization of $17.25 billion, a P/E ratio of 38.25, a PEG ratio of 2.62 and a beta of 0.61. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37. The stock's fifty day moving average price is $146.19 and its 200-day moving average price is $156.10. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the prior year, the firm posted $2.16 EPS. Analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be given a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.49%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox's payout ratio is 133.33%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines